statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Korro to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., Chief Financial Officer...

Piper Sandler Reiterates Overweight Rating for Korro Bio (NASDAQ:KRRO)

Piper Sandler restated their overweight rating on shares of Korro Bio (NASDAQ:KRRO - Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Piper Sandler currently has a...

We Think Korro Bio (NASDAQ:KRRO) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Korro Bio (NASDAQ:KRRO) Price Target Increased to $115.00 by Analysts at HC Wainwright

Korro Bio (NASDAQ:KRRO  Free Report) had its price target lifted by HC Wainwright from $100.00 to $115.00 in a research note published on Thursday, Marketbeat Ratings reports. The firm...

Korro Bio (NASDAQ:KRRO) Rating Reiterated by Piper Sandler

Korro Bio (NASDAQ:KRRO  Get Free Report)s stock had its overweight rating restated by equities research analysts at Piper Sandler in a report issued on Wednesday, Benzinga...

Korro Bio Earns Buy Rating on Promising RNA Editing Technology for AATD Treatment

Analyst Mitchell Kapoor of H.C. Wainwright maintained a Buy rating on Korro Bio (KRRO Research Report), boosting the price target to $115.00. Mit...

Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress

On track for regulatory filing for First-in-Human study of KRRO-110 in Alpha-1 Antitrypsin Deficiency (AATD) patients anticipated in the second half of 2024Demonstrated the versatility of Korro's RNA...

Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Up 12.9% in February

Korro Bio, Inc. (NASDAQ:KRRO  Get Free Report) saw a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 124,000 shares, an...

Korro Bio (KRRO, $60.94) RSI Indicator left the overbought zone on March 15, 2024

This is a signal that KRRO's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Korro Bio (KRRO, $59.14) price may drop as it broke higher Bollinger Band on Mar 14, 2024

This price move could be a signal that KRRO may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Volume	94,134.00
52-Wk High	$97.91
52-Wk Low	$9.15

KRRO Korro Bio Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals